ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2295건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2295 | Terminated | "CHANGE COVID-19 Severity" | COVID-19 Infection | Drug: Magnesium Citrate plus probiotic | Phase 2 | Vanderbilt University Medical Center | OTHER | 23 | All | 18 Years ~ 99 Years | Vanderbilt University Medical Center, Nashville, Tennessee, United States |
| 2294 | Not yet recruiting | "Efesovir" (FS-1) for COVID-19, Phase 2 | Covid19 | Drug: Efesovir | Phase 2 | Scientific Center for Anti-infectious Drugs, Kazakhstan | INDUSTRY | 62 | All | 18 Years ~ 59 Years | Semey Medical University, Semey, East-Kazakhstan Region, Kazakhstan |
| 2293 | Suspended | #StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19 | COVID-19 | Drug: Hydroxychloroquine Drug: Mannitol |
Phase 3 | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | OTHER | 800 | All | 18 Years | Unisante, Lausanne, Vaud, Switzerland |
| 2292 | Active, not recruiting | 101-PGC-005 for the Treatment of COVID-19 | COVID-19 | Drug: 101-PGC-005 Drug: Dexamethasone |
Phase 2 | 101 Therapeutics | INDUSTRY | 62 | All | 18 Years ~ 65 Years | Government Medical College & General Hospital, Srikakulam, Andhra Pradesh, India Victoria Hospital Bangalore, Bangalore, Karnataka, India Sangvi Multispeciality Hospital, Pune, Maharashtra, India SMS Medical College and Attached Hospitals, Jaipur, Rajastan, India Santosh Medical College and Hospital, Gh?zi?b?d, Uttar Pradesh, India |
| 2291 | Completed | A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELLVACCINE TRIAL | COVID-19 | Biological: hAd5-S-Fusion+N-ETSD Biological: Placebo (0.9% (w/v) saline) |
Phase 3 | ImmunityBio, Inc. | INDUSTRY | 35 | All | 16 Years ~ 80 Years | Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States |
| 2290 | Not yet recruiting | A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression | Severe Acute Respiratory Syndrome Coronavirus 2 | Drug: Tafenoquine Oral Tablet Drug: Placebo |
Phase 2 | 60P Australia Pty Ltd | INDUSTRY | 148 | All | 18 Years | |
| 2289 | Terminated | A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia | Undefined | Biological: AT-100 | Phase 1 | Airway Therapeutics, Inc. | INDUSTRY | 5 | All | 18 Years | Airway Therapeutics Investigational Site, Cincinnati, Ohio, United States |
